US45168D1046
US45168D1046
IDEXX Laboratories, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.303.702.000 | 3.897.504.000 | 10.4% |
| Cost of Revenue | 1.644.123.000 | 1.518.577.000 | 8.3% |
| Gross Profit | 2.659.579.000 | 2.378.927.000 | 11.8% |
| 1.299.548.000 | 1.250.590.000 | 3.9% | |
| Operating Income | 1.360.031.000 | 1.128.337.000 | 20.5% |
| Pretax Income | 1.324.189.000 | 1.109.831.000 | 19.3% |
| Net Income Common Stockholders | 1.059.464.000 | 887.867.000 | 19.3% |
| -- | -- | -- | |
| -- | -- | -- |